At Manningham Medical Centre, you can find all the data about High Unmet Medical. We have collected data about general practitioners, medical and surgical specialists, dental, pharmacy and more. Please see the links below for the information you need.


Unmet medical need - National Institutes of Health

    https://toolkit.ncats.nih.gov/glossary/unmet-medical-need/
    An unmet medical need is a condition or symptom whose treatment or diagnosis is not addressed adequately by available therapy. An unmet medical need includes an immediate need for a defined population (e.g., to treat a serious condition with no or …

About | Amgen

    https://www.amgen.com/about
    We focus on six therapeutic areas: cardiovascular disease, oncology, bone health, neuroscience, nephrology and inflammation. Our medicines typically address diseases for which there are limited …

Unmet Medical Needs Persist Across Many Diseases

    https://www.forbes.com/sites/joshuacohen/2018/12/26/unmet-medical-needs-persist-across-many-diseases/
    Unmet medical need is defined conventionally in terms of availability and adequacy of treatments, pharmaceutical or otherwise. Treatments may not exist for …

Target RWE Launches 35 New Disease State Registries …

    https://www.prnewswire.com/news-releases/target-rwe-launches-35-new-disease-state-registries-in-complex-indications-with-high-unmet-medical-needs-and-rapidly-evolving-therapies-301719505.html
    Established in 2019, TARGET-DERM is a longitudinal, observational registry of adult and pediatric patients being managed for Atopic Dermatitis and other immune …

Addressing the Unmet Medical and Social Needs of …

    https://www.healthcarevaluehub.org/advocate-resources/publications/addressing-unmet-medical-and-social-needs-complex-patients

    Pembrolizumab Could Meet Unmet Need in BCG …

      https://www.cancertherapyadvisor.com/home/news/conference-coverage/american-society-of-clinical-oncology-genitourinary-asco-gu/asco-gu-2023/pembrolizumab-nmibc-high-risk-bcg-unresponsive-unmet-need/
      6 hours ago · The median disease-free survival (DFS) for high-risk NMIBC was 7.7 months. The DFS rate was 43.5% at 12 months and 34.9% at both 24 months and 36 months. …

    Medivir to present at the Redeye Fight Cancer Day

      https://finance.yahoo.com/news/medivir-present-redeye-fight-cancer-084100863.html
      Medivir in brief Medivir develops innovative drugs with a focus on cancer where the unmet medical needs are high. The drug candidates are directed toward …

    Cancer-associated miRNAs and their therapeutic potential

      https://pubmed.ncbi.nlm.nih.gov/34088973/
      Abstract. MicroRNA (miRNA; miR) is a functionally small non-coding RNA and can negatively regulate gene expression by directly binding to the target gene. Some miRNAs …

    Bavarian Nordic to Acquire Portfolio of Travel Vaccines

      https://www.globenewswire.com/news-release/2023/02/15/2608323/0/en/Bavarian-Nordic-to-Acquire-Portfolio-of-Travel-Vaccines-from-Emergent-BioSolutions.html
      The vaccine has a highly competitive profile in an area with a high unmet medical need. US-based research and development facilities related to the development …

    New approaches to molecular cancer therapeutics

      https://pubmed.ncbi.nlm.nih.gov/17108987/
      Cancer drug development is leading the way in exploiting molecular biological and genetic information to develop "personalized" medicine. The new paradigm is to develop agents …



    Need more information about High Unmet Medical?

    At Manningham Medical Centre, we collected data on more than just High Unmet Medical. There is a lot of other useful information. Visit the related pages or our most popular pages. Also check out our Doctors page.